Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum- and paclitaxel-refractory ovarian cancer (Q33334292)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum- and paclitaxel-refractory ovarian cancer |
scientific article |
Statements
1 reference
Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum- and paclitaxel-refractory ovarian cancer (English)
1 reference
Markman M
1 reference
Kennedy A
1 reference
Webster K
1 reference
Kulp B
1 reference
Peterson G
1 reference
Belinson J
1 reference
1 October 2000
1 reference
1 reference
Identifiers
1 reference